BARISUR STUDY: DESCRIPTIVE STUDY OF BARICITINIB SAFETY IN SPANISH PATIENTS WITH RHEUMATOID ARTHRITIS

被引:0
|
作者
Rubio Romero, E. [1 ]
Gallego, A. [2 ]
Llanes, M. [3 ]
Delgado Vidal, E. [4 ]
机构
[1] Seville Hosp Univ Virgen Rocio, Rheumatol, Seville, Spain
[2] Hosp Univ Badajoz, Rheumatol, Badajoz, Spain
[3] Hosp Univ Juan Ramon Jimenez, Rheumatol, Huelva, Spain
[4] Rheumatol, Seville, Spain
关键词
Safety; Rheumatoid arthritis; Descriptive studies;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
POS0863
引用
收藏
页码:736 / 736
页数:1
相关论文
共 50 条
  • [21] The Real-World Effectiveness, Persistence, Adherence, and Safety of Janus Kinase Inhibitor Baricitinib in Rheumatoid Arthritis: A Long-Term Study
    Calvo-Garcia, Alberto
    Herraiz, Esther Ramirez
    Cubas, Irene Maria Llorente
    De Dios, Blanca Varas
    Gonzalez, Juana Benedi
    Baladron, Alberto Morell
    Garcia-Vicuna, Rosario
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (09)
  • [22] Janus Kinase Inhibitors in Rheumatoid Arthritis: An Update on the Efficacy and Safety of Tofacitinib, Baricitinib and Upadacitinib
    Harrington, Robert
    Harkins, Patricia
    Conway, Richard
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (20)
  • [23] Is Baricitinib Effective and Safe for Patients with Difficult-to-Treat Rheumatoid Arthritis? Comparative Data with the Rheumatoid Arthritis Group of Rheumatoid Arthritis Not Difficult to Treat
    Ekin, Ali
    Misirci, Salim
    Gorunen, Ahmet
    Coskun, Belkis Nihan
    Yagiz, Burcu
    Dalkilic, Ediz
    Pehlivan, Yavuz
    MEDICAL PRINCIPLES AND PRACTICE, 2025, 34 (01) : 75 - 86
  • [24] Dose reduction of baricitinib in patients with rheumatoid arthritis achieving sustained disease control: results of a prospective study
    Takeuchi, Tsutomu
    Genovese, Mark C.
    Haraoui, Boulos
    Li, Zhanguo
    Xie, Li
    Klar, Rena
    Pinto-Correia, Ana
    Otawa, Susan
    Lopez-Romero, Pedro
    de la Torre, Inmaculada
    Macias, William
    Rooney, Terence P.
    Smolen, Josef S.
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (02) : 171 - 178
  • [25] Safety of Baricitinib 4 mg for the Treatment of Moderate to Severe Rheumatoid Arthritis
    Dabal, Tracey D.
    Haltom, Matthew B.
    Patel, Puja P.
    Son, Christine K.
    Joglekar, Kiran P.
    Groeschell, Charles M.
    Chumpia, Mason M.
    Kamal, Sehrish F.
    Seth, Ankur
    Jackson, Christopher D.
    SOUTHERN MEDICAL JOURNAL, 2021, 114 (05) : 288 - 292
  • [26] Safety of baricitinib in Japanese patients with rheumatoid arthritis in clinical use: 3-year data of all-case postmarketing surveillance study
    Okamoto, Nami
    Atsumi, Tatsuya
    Takagi, Michiaki
    Takahashi, Nobunori
    Takeuchi, Tsutomu
    Tamura, Naoto
    Nakajima, Atsuo
    Nakajima, Ayako
    Fujii, Takao
    Matsuno, Hiroaki
    Ishii, Taeko
    Tsujimoto, Naoto
    Nishikawa, Atsushi
    Minatoya, Machiko
    Tanaka, Yoshiya
    Kuwana, Masataka
    MODERN RHEUMATOLOGY, 2024, 35 (02) : 215 - 224
  • [27] Characteristics of patients with difficult-to-treat rheumatoid arthritis: a descriptive retrospective cohort study
    Qi, Wen
    Robert, Antoine
    Singbo, Narcisse
    Ratelle, Lucie
    Fortin, Paul R.
    Bessette, Louis
    Brown, Jacques P.
    Michou, Laetitia
    ADVANCES IN RHEUMATOLOGY, 2024, 64 (01):
  • [28] Effectiveness and safety study of oral triamcinolone in patients with rheumatoid arthritis in India
    Patil, Nilesh
    INTERNATIONAL JOURNAL OF HEALTH AND ALLIED SCIENCES, 2020, 9 (01) : 14 - 20
  • [29] Response to baricitinib based on prior biologic use in patients with refractory rheumatoid arthritis
    Genovese, Mark C.
    Kremer, Joel M.
    Kartman, Cynthia E.
    Schlichting, Douglas E.
    Xie, Li
    Carmack, Tara
    Pantojas, Carlos
    Sanchez Burson, Juan
    Tony, Hans-Peter
    Macias, William L.
    Rooney, Terence P.
    Smolen, Josef S.
    RHEUMATOLOGY, 2018, 57 (05) : 900 - 908
  • [30] Commercial wrist extensor orthoses: A descriptive study of use and preference in patients with rheumatoid arthritis
    Stern, EB
    Ytterberg, SR
    Larson, LM
    Portoghese, CP
    Kratz, WNR
    Mahowald, ML
    ARTHRITIS CARE AND RESEARCH, 1997, 10 (01): : 27 - 35